HETEROLOGOUS COMBINATIONS OF HEAVY AND LIGHT-CHAINS FROM BOTULINUM NEUROTOXIN-A AND TETANUS TOXIN INHIBIT NEUROTRANSMITTER RELEASE IN APLYSIA

被引:0
|
作者
POULAIN, B
MOCHIDA, S
WELLER, U
HOGY, B
HABERMANN, E
WADSWORTH, JDF
SHONE, CC
DOLLY, JO
TAUC, L
机构
[1] UNIV GIESSEN, R BUCHHEIM INST PHARMAKOL, W-6300 GIESSEN, GERMANY
[2] IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOCHEM, LONDON SW7 2AY, ENGLAND
[3] PUBL HLTH LAB SERV, SALISBURY SP4 0JG, WILTS, ENGLAND
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuroparalytic activities of botulinum neurotoxin type A (BoNT A), tetanus toxin (TeTx), or homologous and heterologous combinations of their constituent polypeptides were examined at cholinergic and non-cholinergic synapses of Aplysia californica. When applied extracellularly, BoNT A or a mixture of its heavy (HC) and light (LC) chains were far more potent in blocking transmitter release at cholinergic than non-cholinergic synapses. The reverse was true for TeTx or a mixture its constituent chains. Such selectivity was assigned to differences in neuronal targetting and uptake of the neurotoxins since both exibited similar potencies when injected directly into the cell body of either cell type. When bath-applied, heterologous combinations of the toxins' HC and LC appeared as effective as the parent neurotoxins from whence each HC was derived. Moreover, targetting/internalization was attributable to the analogous N-terminal moieties, H-2 and beta-2, of the HC from BoNT A and TeTx. Thus, it may be postulated that the latter regions possess two functional domains, one being distinct and responsible for the divergent neuronal specificity, whereas the other serves a common role in translocating the LC of either toxin. Also, it was shown that the C-terminal portion of the HC of TeTx is unable to play the intracellular role of its counterpart in BoNT A.
引用
收藏
页码:9580 / 9585
页数:6
相关论文
共 25 条
  • [21] Botulinum neurotoxin light chains inhibit both Ca2+-induced and CTP analogue-induced catecholamine release from permeabilised adrenal chromaffin cells
    Glenn, DE
    Burgoyne, RD
    FEBS LETTERS, 1996, 386 (2-3) : 137 - 140
  • [22] COOPERATIVE ACTION OF THE LIGHT CHAIN OF TETANUS TOXIN AND THE HEAVY-CHAIN OF BOTULINUM TOXIN TYPE-A ON THE TRANSMITTER RELEASE OF MAMMALIAN MOTOR END-PLATES
    WELLER, U
    DAUZENROTH, ME
    GANSEL, M
    DREYER, F
    NEUROSCIENCE LETTERS, 1991, 122 (01) : 132 - 134
  • [23] TETANUS TOXIN AND BOTULINUM-A TOXIN INHIBIT RELEASE AND UPTAKE OF VARIOUS TRANSMITTERS, AS STUDIED WITH PARTICULATE PREPARATIONS FROM RAT-BRAIN AND SPINAL-CORD
    BIGALKE, H
    HELLER, I
    BIZZINI, B
    HABERMANN, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 316 (03) : 244 - 251
  • [24] Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons
    Joussain, Charles
    Le Coz, Olivier
    Pichugin, Andrey
    Marconi, Peggy
    Lim, Filip
    Sicurella, Mariaconcetta
    Salonia, Andrea
    Montorsi, Francesco
    Wandosell, Francisco
    Foster, Keith
    Giuliano, Francois
    Epstein, Alberto L.
    Munoz, Alejandro Aranda
    TOXINS, 2019, 11 (02):
  • [25] TETANUS TOXIN AND BOTULINUM TOXINS TYPE-A AND TYPE-B INHIBIT GLUTAMATE, GAMMA-AMINOBUTYRIC-ACID, ASPARTATE, AND MET-ENKEPHALIN RELEASE FROM SYNAPTOSOMES - CLUES TO THE LOCUS OF ACTION
    MCMAHON, HT
    FORAN, P
    DOLLY, JO
    VERHAGE, M
    WIEGANT, VM
    NICHOLLS, DG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (30) : 21338 - 21343